Short Summary

Equity in high growth healthcare org + marketing their service for passive income; 187% rise in value in 6mths; Projecting member base of 80k+ members by 2021 and 13x return; Cross exp team of 30+ yrs; Targeting $500k+ funding; Already raised $300k+


Investment Raised
Previous Rounds A$40,000
Stage Pre-Startup/R&D
Investor Role Any


  • Company value risen by 220%(6 months); Approval rating over 95%
  • Passive income of $4000 /month/share by EOY 2021
  • EOY 2021 payout of $65k for each $5k share (13x)
  • Targeting the $130bn market
  • Already raised A$350,000
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
56% raised

Secure Health Chain

location_on New South Wales, Australia

Pioneering a unique and secure platform, to collect, collate, store and share data. A common final pathway for all interactions within the healthcare system. Revolutionising the way health records are stored, used and now monetised.

A$ 800,000


A$ 50,000

Min per Investor

Global Pro
1% raised

AUS Pharma High ROI

location_on New South Wales,

All economic data is showing that South-East Asia is the next big thing following China's trajectory. Join an Australian company in its entry into the South-East Asian Vitamin and Supplements Industry starting with The Philippines.

A$ 4,500,000


A$ 10,000

Min per Investor

Global Pro
25% raised

Cure For Heart Disease

location_on Queensland, Australia

Heart disease is Australia’s number one killer. Our company has pioneered a new compound that reduces cholesterol and plaque build-up in humans. We are government approved and preparing to retail our products.

A$ 800,000


A$ 10,000

Min per Investor

load one similar proposal